Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia.

Yamakawa, Tadashi

Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia. [electronic resource] - Endocrine journal 2011 - 185-91 p. digital

Publication Type: Comparative Study; Journal Article

1348-4540

10.1507/endocrj.k10e-255 doi


Aged
Atorvastatin
Blood Glucose--drug effects
Comorbidity
Diabetes Mellitus, Type 2--blood
Epichlorohydrin--pharmacology
Female
Glycated Hemoglobin--drug effects
Heptanoic Acids--pharmacology
Humans
Hypercholesterolemia--blood
Hypoglycemic Agents--pharmacology
Imidazoles--pharmacology
Lipids--blood
Male
Middle Aged
Multivariate Analysis
Pravastatin--pharmacology
Pyrroles--pharmacology
Quinolines--pharmacology
Resins, Synthetic--pharmacology
Retrospective Studies
Treatment Outcome